Mobile App for Mood in Pregnancy (Ginger iO)

The Mobile Mood Tracking App study is a small randomized trial of acceptability and usability of a mobile phone mood tracking application (mobile app) among women with depressed mood in pregnancy. The study will be assessing the perceived value and usability of this tool in pregnancy over eight weeks to test whether women using this app are more likely to receive assessments and treatments of depressed mood than women not using it.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mood Disorders Behavior Behavioral Symptoms Depression Mental Disorders

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Dickens Center for Women's Health at the Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Positive screening for elevated depression symptomatology (PHQ-9 score must be greater than or equal to 5.)

Exclusion criteria

Women with pregnancies of less than 33 weeks gestation.

Treatment and study plan

No intervention

Other

Primary outcomes

Evidence of increased provider intervention for the treatment of worsening depressive symptoms confirmed by the mobile mood tracking application.

Time frame: 8 weeks

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

Ginger.io

Registry information

Important dates

Study start: 2015
Primary completion: 2015
First posted: May 4, 2016
Registry last updated: May 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed